Per Wold-Olsen is a Norwegian businessperson who has been the head of 8 different companies. Currently, he occupies the position of Chairman for Oncopeptides AB and Chairman for GN Store Nord A, Chairman for GN Audio A, Chairman of GN Hearing An and Chairman for GN Netcom A (which are all subsidiaries of GN Store Nord A).
He is also on the board of Gilead Sciences, Inc. and Bio Malter and Chairman for Medicines for Malaria Venture.
In his past career Mr. Wold-Olsen held the position of Regional Director & Vice President at MSD Scandinavia AS, President-Intercontinental Division at Merck & Co., Inc. and Chief Executive Officer at MSD (Norge) AS (a subsidiary of Merck & Co., Inc.) and Chairman-Supervisory Board at H. Lundbeck A.
He received an MBA from the University of Wisconsin.